Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLSA3.SA Stock Summary
Top 10 Correlated ETFs
CLSA3.SA
In the News
CLSA3.SA Financial details
Company Rating
Neutral
Market Cap
1.27B
Income
-28.08M
Revenue
504.06M
Book val./share
3.84
Cash/share
2.1
Dividend
-
Dividend %
-
Employees
1.99K
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-25.73
Forward P/E
-
PEG
10.17
P/S
1.39
P/B
1.01
P/C
3.8
P/FCF
-10.46
Quick Ratio
2.52
Current Ratio
3.59
Debt / Equity
0.04
LT Debt / Equity
0
-
-
EPS (TTM)
-0.15
EPS next Y
-
EPS next Q
-
EPS this Y
-25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
19.31%
Revenue Q/Q
12.03%
EPS Q/Q
-137.52%
-
-
-
-
SMA20
69.73%
SMA50
107.27%
SMA100
71.86%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-4%
ROC
-0.05%
Gross Margin
36%
Oper. Margin
-8%
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.95-7.66
52W High
+14%
52W Low
+299%
RSI
83.59
Rel Volume
2.23
Avg Volume
1.25M
Volume
2.8M
Perf Week
25.27%
Perf Month
119.83%
Perf Quarter
102.03%
Perf Half Y
84.72%
-
-
-
-
Beta
0.418
-
-
Volatility
0.48%, 1.25%
Prev Close
9.32%
Price
7.98
Change
9.77%
CLSA3.SA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.16 | 1.91 | 2.71 | 2.71 | 2.68 | |
Net income per share | 0.92 | 0.17 | -0.44 | -0.2 | -0.15 | |
Operating cash flow per share | 0.72 | 0.16 | -0.07 | -0.25 | 0.24 | |
Free cash flow per share | -0.27 | 0.03 | -0.38 | -0.83 | -0.25 | |
Cash per share | 2.17 | 0.32 | 4.42 | 2.56 | 2.1 | |
Book value per share | 3.04 | 0.08 | 4.6 | 3.97 | 3.84 | |
Tangible book value per share | 0.59 | -0.13 | 4.22 | 2.77 | 2.29 | |
Share holders equity per share | 3.04 | 0.08 | 4.6 | 3.97 | 3.84 | |
Interest debt per share | 4.82 | 0.65 | 0.71 | 0.38 | 0.22 | |
Market cap | 323.12M | 5.38B | 1.52B | 994.14M | 667.14M | |
Enterprise value | 348.69M | 5.43B | 883.74M | 577.27M | 319.22M | |
P/E ratio | 32.31 | 176.76 | -20.39 | -26.82 | -23.82 | |
Price to sales ratio | 1.55 | 15.56 | 3.32 | 1.95 | 1.32 | |
POCF ratio | 41.44 | 191.42 | -132.68 | -21.26 | 15.03 | |
PFCF ratio | -111.31 | 1.14K | -23.6 | -6.34 | -14.07 | |
P/B Ratio | 9.77 | 387.03 | 1.96 | 1.33 | 0.93 | |
PTB ratio | 9.77 | 387.03 | 1.96 | 1.33 | 0.93 | |
EV to sales | 1.67 | 15.71 | 1.93 | 1.13 | 0.63 | |
Enterprise value over EBITDA | 11.31 | 77.24 | -11.98 | -10.73 | -7.93 | |
EV to operating cash flow | 44.72 | 193.28 | -77.16 | -12.34 | 7.19 | |
EV to free cash flow | -120.11 | 1.15K | -13.73 | -3.68 | -6.73 | |
Earnings yield | 0.03 | 0.01 | -0.05 | -0.04 | -0.04 | |
Free cash flow yield | -0.01 | 0 | -0.04 | -0.16 | -0.07 | |
Debt to equity | 1.49 | 7.73 | 0.14 | 0.08 | 0.04 | |
Debt to assets | 0.38 | 0.49 | 0.11 | 0.07 | 0.04 | |
Net debt to EBITDA | 0.83 | 0.74 | 8.62 | 7.75 | 8.65 | |
Current ratio | 1.56 | 1.45 | 6.22 | 4.98 | 3.88 | |
Interest coverage | 7.03 | 5.9 | -7.49 | -9.38 | -8.63 | |
Income quality | 1.41 | 1.5 | 0.15 | 1.26 | -1.59 | |
Dividend Yield | 0.03 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 1 | 0.88 | -0.17 | 0 | 0 | |
Sales general and administrative to revenue | 0.38 | 0.32 | 0.51 | 0.51 | 0.49 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.2 | 0.17 | 0.07 | 0.25 | 0.33 | |
Capex to operating cash flow | -1.37 | -0.83 | 4.62 | 2.36 | -2.07 | |
Capex to revenue | -0.05 | -0.07 | -0.12 | -0.22 | -0.18 | |
Capex to depreciation | -1.41 | -2.32 | -3.47 | -3.58 | -2.07 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.1 | 0.02 | 0 | |
Graham number | 7.93 | 0.54 | 6.76 | 4.19 | 3.59 | |
ROIC | 0.12 | 0.26 | -0.12 | -0.13 | -0.08 | |
Return on tangible assets | 0.1 | 0.17 | -0.08 | -0.05 | -0.05 | |
Graham Net | -2.76 | -0.44 | 3.76 | 2.33 | 1.84 | |
Working capital | 30.25M | 48.1M | 743.12M | 526.62M | 412.81M | |
Tangible asset value | 6.4M | -23.08M | 712.55M | 520.73M | 430.79M | |
Net current asset value | -12.65M | -48.88M | 674.82M | 488.58M | 395.88M | |
Invested capital | 1.49 | 7.73 | 0.14 | 0.08 | 0.04 | |
Average receivables | 28.93M | 73.7M | 111.58M | 151.4M | 158.58M | |
Average payables | 3.08M | 9.87M | 21.84M | 28.29M | 28.88M | |
Average inventory | 0 | -1.54M | -2.31M | -1.55M | -783.5K | |
Days sales outstanding | 101.29 | 94.56 | 106.61 | 121.15 | 107.15 | |
Days payables outstanding | 14.06 | 33.51 | 35.6 | 31.37 | 31.13 | |
Days of inventory on hand | 0 | -6.56 | -1.96 | -1.72 | 0 | |
Receivables turnover | 3.6 | 3.86 | 3.42 | 3.01 | 3.41 | |
Payables turnover | 25.96 | 10.89 | 10.25 | 11.64 | 11.73 | |
Inventory turnover | 0 | -55.65 | -186.5 | -212.78 | 0 | |
ROE | 0.3 | 2.19 | -0.1 | -0.05 | -0.04 | |
Capex per share | -0.98 | -0.13 | -0.31 | -0.59 | -0.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.8 | 0.66 | 0.67 | 0.63 | 0.71 | |
Net income per share | 0.03 | -0.09 | -0.01 | -0.07 | 0.03 | |
Operating cash flow per share | 0.01 | 0.14 | 0.03 | 0.01 | 0.06 | |
Free cash flow per share | -0.16 | -0.01 | -0.09 | -0.11 | -0.04 | |
Cash per share | 2.56 | 2.49 | 2.36 | 2.2 | 2.1 | |
Book value per share | 3.97 | 3.88 | 3.87 | 3.81 | 3.84 | |
Tangible book value per share | 2.77 | 2.61 | 2.52 | 2.36 | 2.29 | |
Share holders equity per share | 3.97 | 3.88 | 3.87 | 3.81 | 3.84 | |
Interest debt per share | 0.34 | 0.31 | 0.26 | 0.25 | 0.18 | |
Market cap | 994.13M | 1.06B | 1.26B | 877.61M | 667.14M | |
Enterprise value | 577.25M | 650.26M | 888.46M | 524.95M | 319.22M | |
P/E ratio | 47.91 | -15.2 | -168.15 | -15.75 | 31.91 | |
Price to sales ratio | 6.59 | 8.54 | 9.95 | 7.36 | 4.99 | |
POCF ratio | 599.96 | 41.23 | 204.2 | 741.86 | 59.27 | |
PFCF ratio | -33.21 | -611.3 | -74.94 | -42.37 | -81.7 | |
P/B Ratio | 1.33 | 1.46 | 1.73 | 1.23 | 0.93 | |
PTB ratio | 1.33 | 1.46 | 1.73 | 1.23 | 0.93 | |
EV to sales | 3.83 | 5.22 | 7.02 | 4.4 | 2.39 | |
Enterprise value over EBITDA | 89.16 | -250.1 | 84.58 | -44.9 | 38.86 | |
EV to operating cash flow | 348.37 | 25.2 | 144.09 | 443.75 | 28.36 | |
EV to free cash flow | -19.29 | -373.71 | -52.88 | -25.35 | -39.09 | |
Earnings yield | 0.01 | -0.02 | 0 | -0.02 | 0.01 | |
Free cash flow yield | -0.03 | 0 | -0.01 | -0.02 | -0.01 | |
Debt to equity | 0.08 | 0.07 | 0.06 | 0.06 | 0.04 | |
Debt to assets | 0.07 | 0.06 | 0.05 | 0.05 | 0.04 | |
Net debt to EBITDA | -64.39 | 159 | -35.29 | 30.16 | -42.36 | |
Current ratio | 4.98 | 4.39 | 4.15 | 3.59 | 3.88 | |
Interest coverage | -1.59 | -2.69 | -0.18 | -9.19 | -1.2 | |
Income quality | 0.32 | -1.48 | -3.29 | -0.08 | 2.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.48 | 0.14 | 0 | 0.56 | 0.43 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.25 | 0.27 | 0.28 | 0.3 | 0.33 | |
Capex to operating cash flow | -19.06 | -1.07 | -3.72 | -18.51 | -1.73 | |
Capex to revenue | -0.21 | -0.22 | -0.18 | -0.18 | -0.15 | |
Capex to depreciation | -3.23 | -2.66 | -2.1 | -1.88 | -1.7 | |
Stock based compensation to revenue | 0.04 | 0.03 | -0.01 | 0 | 0 | |
Graham number | 1.57 | 2.85 | 0.93 | 2.52 | 1.55 | |
ROIC | 0 | -0.02 | 0 | -0.02 | 0 | |
Return on tangible assets | 0.01 | -0.03 | 0 | -0.02 | 0.01 | |
Graham Net | 2.33 | 2.18 | 2.02 | 1.85 | 1.84 | |
Working capital | 526.62M | 484.3M | 463.36M | 425.84M | 412.81M | |
Tangible asset value | 520.73M | 490.2M | 474.34M | 442.76M | 430.79M | |
Net current asset value | 488.58M | 457.9M | 442.31M | 407.84M | 395.88M | |
Invested capital | 0.08 | 0.07 | 0.06 | 0.06 | 0.04 | |
Average receivables | 159.91M | 157.69M | 142.99M | 147.38M | 151.49M | |
Average payables | 24.3M | 30.18M | 32.32M | 31.03M | 29.11M | |
Average inventory | -1.6M | -806K | -1.08M | -1.06M | 0 | |
Days sales outstanding | 100.9 | 105.62 | 99.39 | 116.95 | 99.67 | |
Days payables outstanding | 32.06 | 35.84 | 35.95 | 28.79 | 32.81 | |
Days of inventory on hand | -1.75 | -0.05 | -2.31 | 0 | 0 | |
Receivables turnover | 0.89 | 0.85 | 0.91 | 0.77 | 0.9 | |
Payables turnover | 2.81 | 2.51 | 2.5 | 3.13 | 2.74 | |
Inventory turnover | -51.33 | -1.77K | -39 | 0 | 0 | |
ROE | 0.01 | -0.02 | 0 | -0.02 | 0.01 | |
Capex per share | -0.17 | -0.15 | -0.12 | -0.12 | -0.1 |
CLSA3.SA Frequently Asked Questions
What is ClearSale S.A. stock symbol ?
ClearSale S.A. is a BR stock , located in São paulo of Sp and trading under the symbol CLSA3.SA
What is ClearSale S.A. stock quote today ?
ClearSale S.A. stock price is $7.98 today.
Is ClearSale S.A. stock public?
Yes, ClearSale S.A. is a publicly traded company.